{"entity":{"type":"insider","cik":"0001800690","url":"/insider/0001800690","json_url":"/insider/0001800690.json","name":"TardiMed Sciences LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":11,"first":"2020-02-12","last":"2022-09-01","span_basis":"filed_date"},"name_variants":[{"name":"TardiMed Sciences LLC","source":"filing","n_filings":11,"first_seen":"2020-02-12","last_seen":"2022-09-01"}],"transactions":[{"id":6961652,"accession":"0001104659-22-097019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-097019","line_url":"/filing/0001104659-22-097019#line-1","is_derivative":false,"issuer_cik":"0001800690","issuer_name":"PaxMedica, Inc.","issuer_ticker":"PXMD","issuer_name_source":null,"issuer_url":"/issuer/0001800690","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":95000.0,"shares_display":"95,000","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":498750.0,"total_display":"498,750.00","total_whole":"498,750","shares_owned_after":7336745.0,"shares_owned_after_display":"7,336,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-30","filed_date":"2022-09-01","scope":"insider"},{"id":4366016,"accession":"0001104659-21-112596","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-112596","line_url":"/filing/0001104659-21-112596#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225000.0,"shares_display":"225,000","price_per_share":0.9376,"price_display":"0.94","price_state":"stated","total_value":210960.0,"total_display":"210,960.00","total_whole":"210,960","shares_owned_after":3508567.0,"shares_owned_after_display":"3,508,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-02","scope":"insider"},{"id":5502115,"accession":"0001104659-21-112122","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-112122","line_url":"/filing/0001104659-21-112122#line-3","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150500.0,"shares_display":"150,500","price_per_share":0.9227,"price_display":"0.92","price_state":"stated","total_value":138866.35,"total_display":"138,866.35","total_whole":"138,866","shares_owned_after":3733567.0,"shares_owned_after_display":"3,733,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-01","scope":"insider"},{"id":5502113,"accession":"0001104659-21-112122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-112122","line_url":"/filing/0001104659-21-112122#line-2","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":0.9116,"price_display":"0.91","price_state":"stated","total_value":136740.0,"total_display":"136,740.00","total_whole":"136,740","shares_owned_after":3884067.0,"shares_owned_after_display":"3,884,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-31","filed_date":"2021-09-01","scope":"insider"},{"id":5502110,"accession":"0001104659-21-112122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-112122","line_url":"/filing/0001104659-21-112122#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.9266,"price_display":"0.93","price_state":"stated","total_value":92660.0,"total_display":"92,660.00","total_whole":"92,660","shares_owned_after":4034067.0,"shares_owned_after_display":"4,034,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-09-01","scope":"insider"},{"id":5536422,"accession":"0001104659-21-109895","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-109895","line_url":"/filing/0001104659-21-109895#line-3","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.9184,"price_display":"0.92","price_state":"stated","total_value":91840.0,"total_display":"91,840.00","total_whole":"91,840","shares_owned_after":4134067.0,"shares_owned_after_display":"4,134,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-26","scope":"insider"},{"id":5536419,"accession":"0001104659-21-109895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-109895","line_url":"/filing/0001104659-21-109895#line-2","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.9126,"price_display":"0.91","price_state":"stated","total_value":91260.0,"total_display":"91,260.00","total_whole":"91,260","shares_owned_after":4234067.0,"shares_owned_after_display":"4,234,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-25","filed_date":"2021-08-26","scope":"insider"},{"id":5536416,"accession":"0001104659-21-109895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-109895","line_url":"/filing/0001104659-21-109895#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.9253,"price_display":"0.93","price_state":"stated","total_value":92530.0,"total_display":"92,530.00","total_whole":"92,530","shares_owned_after":4334067.0,"shares_owned_after_display":"4,334,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-24","filed_date":"2021-08-26","scope":"insider"},{"id":5459908,"accession":"0001104659-21-108259","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-108259","line_url":"/filing/0001104659-21-108259#line-3","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.9079,"price_display":"0.91","price_state":"stated","total_value":45395.0,"total_display":"45,395.00","total_whole":"45,395","shares_owned_after":4434067.0,"shares_owned_after_display":"4,434,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-20","filed_date":"2021-08-20","scope":"insider"},{"id":5459906,"accession":"0001104659-21-108259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-108259","line_url":"/filing/0001104659-21-108259#line-2","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.954,"price_display":"0.95","price_state":"stated","total_value":47700.0,"total_display":"47,700.00","total_whole":"47,700","shares_owned_after":4484067.0,"shares_owned_after_display":"4,484,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider"},{"id":5459902,"accession":"0001104659-21-108259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-108259","line_url":"/filing/0001104659-21-108259#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":1.001,"price_display":"1.00","price_state":"stated","total_value":75075.0,"total_display":"75,075.00","total_whole":"75,075","shares_owned_after":4534067.0,"shares_owned_after_display":"4,534,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-20","scope":"insider"},{"id":5282138,"accession":"0001104659-21-081618","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-081618","line_url":"/filing/0001104659-21-081618#line-2","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28450.0,"shares_display":"28,450","price_per_share":1.2627,"price_display":"1.26","price_state":"stated","total_value":35923.815,"total_display":"35,923.82","total_whole":"35,924","shares_owned_after":4609067.0,"shares_owned_after_display":"4,609,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-15","scope":"insider"},{"id":5282134,"accession":"0001104659-21-081618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-081618","line_url":"/filing/0001104659-21-081618#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146465.0,"shares_display":"146,465","price_per_share":1.2669,"price_display":"1.27","price_state":"stated","total_value":185556.5085,"total_display":"185,556.51","total_whole":"185,557","shares_owned_after":4637517.0,"shares_owned_after_display":"4,637,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-15","scope":"insider"},{"id":4312162,"accession":"0001104659-21-079574","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-079574","line_url":"/filing/0001104659-21-079574#line-3","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185229.0,"shares_display":"185,229","price_per_share":1.2629,"price_display":"1.26","price_state":"stated","total_value":233925.7041,"total_display":"233,925.70","total_whole":"233,926","shares_owned_after":4783982.0,"shares_owned_after_display":"4,783,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-10","scope":"insider"},{"id":4312158,"accession":"0001104659-21-079574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-079574","line_url":"/filing/0001104659-21-079574#line-2","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96481.0,"shares_display":"96,481","price_per_share":1.2739,"price_display":"1.27","price_state":"stated","total_value":122907.1459,"total_display":"122,907.15","total_whole":"122,907","shares_owned_after":4969211.0,"shares_owned_after_display":"4,969,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-10","scope":"insider"},{"id":4312153,"accession":"0001104659-21-079574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-079574","line_url":"/filing/0001104659-21-079574#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":305540.0,"shares_display":"305,540","price_per_share":1.2875,"price_display":"1.29","price_state":"stated","total_value":393382.75,"total_display":"393,382.75","total_whole":"393,383","shares_owned_after":5065692.0,"shares_owned_after_display":"5,065,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-10","scope":"insider"},{"id":5404035,"accession":"0001104659-21-075875","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-075875","line_url":"/filing/0001104659-21-075875#line-3","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9879.0,"shares_display":"9,879","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":12447.54,"total_display":"12,447.54","total_whole":"12,448","shares_owned_after":5371232.0,"shares_owned_after_display":"5,371,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-02","scope":"insider"},{"id":5404033,"accession":"0001104659-21-075875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-075875","line_url":"/filing/0001104659-21-075875#line-2","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8670.0,"shares_display":"8,670","price_per_share":1.2632,"price_display":"1.26","price_state":"stated","total_value":10951.944,"total_display":"10,951.94","total_whole":"10,952","shares_owned_after":5381111.0,"shares_owned_after_display":"5,381,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":5404030,"accession":"0001104659-21-075875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-075875","line_url":"/filing/0001104659-21-075875#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47736.0,"shares_display":"47,736","price_per_share":1.2699,"price_display":"1.27","price_state":"stated","total_value":60619.9464,"total_display":"60,619.95","total_whole":"60,620","shares_owned_after":5389781.0,"shares_owned_after_display":"5,389,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-06-02","scope":"insider"},{"id":3076267,"accession":"0000905718-20-000959","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905718-20-000959","line_url":"/filing/0000905718-20-000959#line-3","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100694.0,"shares_display":"100,694","price_per_share":1.0298,"price_display":"1.03","price_state":"stated","total_value":103694.6812,"total_display":"103,694.68","total_whole":"103,695","shares_owned_after":5437517.0,"shares_owned_after_display":"5,437,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-16","filed_date":"2020-09-16","scope":"insider"},{"id":3076260,"accession":"0000905718-20-000959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-20-000959","line_url":"/filing/0000905718-20-000959#line-2","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87060.0,"shares_display":"87,060","price_per_share":1.0286,"price_display":"1.03","price_state":"stated","total_value":89549.916,"total_display":"89,549.92","total_whole":"89,550","shares_owned_after":5538211.0,"shares_owned_after_display":"5,538,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-16","scope":"insider"},{"id":3076252,"accession":"0000905718-20-000959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-000959","line_url":"/filing/0000905718-20-000959#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":455.0,"shares_display":"455","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":468.65,"total_display":"468.65","total_whole":"469","shares_owned_after":5625271.0,"shares_owned_after_display":"5,625,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-16","scope":"insider"},{"id":3204325,"accession":"0000905718-20-000947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-20-000947","line_url":"/filing/0000905718-20-000947#line-2","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7483.0,"shares_display":"7,483","price_per_share":1.0303,"price_display":"1.03","price_state":"stated","total_value":7709.7349,"total_display":"7,709.73","total_whole":"7,710","shares_owned_after":5625726.0,"shares_owned_after_display":"5,625,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-14","scope":"insider"},{"id":3204318,"accession":"0000905718-20-000947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-000947","line_url":"/filing/0000905718-20-000947#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"Timber Pharmaceuticals, Inc.","issuer_ticker":"TMBR","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32943.0,"shares_display":"32,943","price_per_share":1.0436,"price_display":"1.04","price_state":"stated","total_value":34379.3148,"total_display":"34,379.31","total_whole":"34,379","shares_owned_after":5633209.0,"shares_owned_after_display":"5,633,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-14","scope":"insider"},{"id":2209146,"accession":"0000905718-20-000119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-000119","line_url":"/filing/0000905718-20-000119#line-1","is_derivative":false,"issuer_cik":"0001504167","issuer_name":"BioPharmX Corp","issuer_ticker":"BPMX","issuer_name_source":null,"issuer_url":"/issuer/0001504167","owner_cik":"0001800690","owner_name":"TardiMed Sciences LLC","owner_display_name":"TardiMed Sciences LLC","owner_url":"/insider/0001800690","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55008.0,"shares_display":"55,008","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":550.08,"total_display":"550.08","total_whole":"550","shares_owned_after":2200328.0,"shares_owned_after_display":"2,200,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001811623","name":"PaxMedica, Inc.","url":"/issuer/0001811623","role":"Ten percent owner","n_filings":1,"first_seen":"2022-09-01","last_seen":"2022-09-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001504167","name":"Timber Pharmaceuticals, Inc.","url":"/issuer/0001504167","role":"Ten percent owner","n_filings":10,"first_seen":"2020-02-12","last_seen":"2021-09-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001800690","retrieved_at":"2026-08-23T00:31:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}